CORRUNA, Mich. (WJRT) - Sentencing day for Mark Latunski didn t take away the pain for Kevin Bacon s family, but it hopefully brought an end to the legal ordeal.
CORUNNA, Mich. (WJRT) - Sentencing day for Mark David Latunski didn t take away the pain for Kevin Bacon s family, but it hopefully brought an end to the legal ordeal.
Mark David Latunski was sentenced to life in prison with no chance of parole on Thursday morning after admitting he murdered 25-year-old Kevin Bacon around Christmas of 2019.
Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple myeloma
News provided by
Share this article
STOCKHOLM, March 8, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO
), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that it strengthens the leadership of the European operations by appointing Andrea Passalacqua as General Manager in Europe, and Pamela Bacon as Head of Medical Affairs Europe. The Company also announced that it opens an Early Access Program across Europe to address the significant need of new treatment alternatives in multiple myeloma. As previously announced, Oncopeptides will also seek a Conditional Marketing Authorization of melphalan flufenamide in triple class refractory multiple myeloma, during second quarter of 2021.